期刊
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
卷 175, 期 6, 页码 2986-2995出版社
HUMANA PRESS INC
DOI: 10.1007/s12010-014-1466-1
关键词
Fermentation; Heparin; Sulfotransferase; Epimerase; Recombinant enzymes
资金
- NIH [HL096972]
- National Natural Science Foundation of China [31171737]
- PRC [210208310507]
- Bioengineered Heparin Consortium
Bioengineered heparin is being investigated as a potential substitute for the animal-sourced anticoagulant drug. One step in the current process to prepare bioengineered heparin involves the conversion of N-sulfo heparosan, rich in -> aEuro parts per thousand 4)GlcNS(1 -> aEuro parts per thousand 4) GlcA(1 -> aEuro parts per thousand sequences (where S is sulfo, GlcN is alpha-d-glucosamine, and GlcA is beta-d-glucuronic acid), to a critical intermediate, rich in -> aEuro parts per thousand 4)GlcNS(1 -> aEuro parts per thousand 4) IdoA2S(1 -> aEuro parts per thousand sequences (where S is sulfo and IdoA is alpha-l-iduronic acid), using 2-O-sulfotransferase (2-OST) and C5 epimerase (C-5-epi). Until now, these heparan sulfate biosynthetic enzymes have been expressed in Escherichia coli grown in shake flask culture as fusion proteins. The current study is focused on the high cell density fed-batch cultivation of recombinant E. coli strains expressing both enzymes. We report the high productivity expression of active 2-OST and C-5-epi enzymes of 6.0 and 2.2 mg/g dry cell weight, respectively.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据